Dual Labeling of Primary Cells with Fluorescent Gadolinium Oxide Nanoparticles.

Autor: Brune N; Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany., Mues B; Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany., Buhl EM; Institute of Pathology, Electron Microscopy Facility, University Clinic Aachen, 52074 Aachen, Germany., Hintzen KW; Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.; DWI-Leibniz-Institute for Interactive Materials, 52074 Aachen, Germany., Jockenhoevel S; Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.; Aachen-Maastricht Institute for Biobased Materials, Faculty of Science and Engineering, Maastricht University, 6167 RD Geleen, The Netherlands., Cornelissen CG; Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.; Department of Pneumology and Internal Intensive Care Medicine, Medical Clinic V, University Clinic Aachen, 52074 Aachen, Germany., Slabu I; Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany., Thiebes AL; Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.; Aachen-Maastricht Institute for Biobased Materials, Faculty of Science and Engineering, Maastricht University, 6167 RD Geleen, The Netherlands.
Jazyk: angličtina
Zdroj: Nanomaterials (Basel, Switzerland) [Nanomaterials (Basel)] 2023 Jun 16; Vol. 13 (12). Date of Electronic Publication: 2023 Jun 16.
DOI: 10.3390/nano13121869
Abstrakt: The interest in mesenchymal stromal cells as a therapy option is increasing rapidly. To improve their implementation, location, and distribution, the properties of these must be investigated. Therefore, cells can be labeled with nanoparticles as a dual contrast agent for fluorescence and magnetic resonance imaging (MRI). In this study, a more efficient protocol for an easy synthesis of rose bengal-dextran-coated gadolinium oxide (Gd 2 O 3 -dex-RB) nanoparticles within only 4 h was established. Nanoparticles were characterized by zeta potential measurements, photometric measurements, fluorescence and transmission electron microscopy, and MRI. In vitro cell experiments with SK-MEL-28 and primary adipose-derived mesenchymal stromal cells (ASC), nanoparticle internalization, fluorescence and MRI properties, and cell proliferation were performed. The synthesis of Gd 2 O 3 -dex-RB nanoparticles was successful, and they were proven to show adequate signaling in fluorescence microscopy and MRI. Nanoparticles were internalized into SK-MEL-28 and ASC via endocytosis. Labeled cells showed sufficient fluorescence and MRI signal. Labeling concentrations of up to 4 mM and 8 mM for ASC and SK-MEL-28, respectively, did not interfere with cell viability and proliferation. Gd 2 O 3 -dex-RB nanoparticles are a feasible contrast agent to track cells via fluorescence microscopy and MRI. Fluorescence microscopy is a suitable method to track cells in in vitro experiments with smaller samples.
Databáze: MEDLINE